XRP6258 Plus Prednisone Compared to Mitoxantrone Plus Prednisone in Hormone Refractory Metastatic Prostate Cancer
OGX-427 in Castration Resistant Prostate Cancer Patients
|3||Active, not recruiting||
Radiotherapy for Oligometastatic Prostate Cancer
|4||Active, not recruiting||
Alisertib, Abiraterone Acetate and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer
Cabazitaxel - PF Induction Chemotherapy
† Study has passed its completion date and status has not been verified in more than two years.